Skip to main content
. 2016 Oct 18;17(10):1540. doi: 10.3390/ijms17101540

Table 3.

Stratification analysis by clinical-pathological parameters in breast cancer patients.

Parameters GA + AA Cases/Controls 1 GG Cases/Controls 2 OR Adjusted (95% CI) p 3
Age
<55 (mean) 21 17 1.13 (0.55–2.31) 0.857
≥55 (mean) 23 18 0.91 (0.44–1.87) 0.854
Tumor site
Ductal 21 13 1.15 (0.52–2.52) 0.843
Lobular 1 - - 1.000
Lymphovascular invasion
Positive 24 16 1.07 (0.51–2.22) 1.000
Negative 13 12 0.77 (0.32–1.84) 0.656
RP
Positive 21 13 1.15 (0.52–2.52) 0.843
Negative 6 5 0.85 (0.25–2.96) 1.000
RE
Positive 22 13 1.21 (0.55–2.63) 0.697
Negative 9 3 2.13 (0.55–8.32) 0.359
HER2
Positive 10 9 0.79 (0.29–2.09) 0.803
Negative 20 8 1.78 (0.72–4.38) 0.280
Histological grade
Grade I 4 4 0.71 (0.17–2.99) 0.720
Grade II 26 18 1.02 (0.51–2.08) 1.000
Grade III 13 10 0.92 (0.37–2.28) 1.000
Menopausal period
Premenopausal 12 14 0.61 (0.26–1.44) 0.280
Postmenopausal 24 17 1.01 (0.48–2.07) 1.000

1 Controls: GA + AA = 66; 2 Controls: GG = 47; 3 Adjustment obtained in logistic regression models.